neos
therapeutics
host
third
quarter
financial
operating
results
conference
call
november
dallas
fort
worth
texas
globe
newswire
neos
therapeutics
nasdaq
neos
pharmaceutical
company
developing
manufacturing
central
nervous
products
today
announced
report
third
quarter
financial
results
opening
financial
markets
monday
november
neos
management
host
conference
call
live
audio
webcast
discuss
results
provide
company
update
et
day
live
call
may
accessed
dialing
domestic
calls
international
callers
referencing
conference
id
number
live
audio
webcast
conference
call
available
investor
relations
page
company
website
http
available
replay
following
call
days
neos
therapeutics
neos
therapeutics
nasdaq
neos
pharmaceutical
company
utilizing
novel
microparticle
delivery
technology
develop
manufacture
central
nervous
system
cns
products
adzenys
amphetamine
orally
disintegrating
tablets
see
full
prescribing
information
including
boxed
warning
cotempla
methylphenidate
orally
disintegrating
tablets
see
full
prescribing
information
including
boxed
warning
amphetamine
oral
suspension
see
full
prescribing
information
including
boxed
warning
treatment
adhd
three
approved
products
utilizing
company
novel
microparticle
delivery
technology
additional
information
neos
available
contacts
richard
eisenstadt
chief
financial
officer
neos
therapeutics
reisenstadt
sarah
mccabe
investor
relations
stern
investor
relations
